Logan Zemp
@LoganZemp
Followers
724
Following
1K
Media
56
Statuses
569
Urologic Oncologist @Moffittnews via @MoffittGuONC & @UrologyAlberta | šØš¦ | If you hang out at the barbershop long enough, youāll eventually get a haircut
Tampa, FL
Joined February 2020
RT @UrologyCareFdn: š The @AmerUrological and the UCF are excited to recognize 12 researchers as recipients of the 2025 Urology Care Foundaā¦.
0
5
0
RT @bbmdmsk: A very sad day learning that a giant in urology passed, Donald G. Skinner MD His impact was profound. His commitment to surgiā¦.
0
31
0
Welcome to the @MoffittNews family! The future is bright! @SUO_YUO @UroOnc @AmerUrological @MUSC_Urology @Yale_Urology @GUUrology.
Congrats @GabrielleYanke2 @BMoraGarijo , Dr. Syed Rahman on matching with Moffitt GU Onc. weāre super excited youāll be joining us next year!!
2
7
42
RT @siadaneshmand: Couldnāt agree more. @LeileiXiaUro found similar results in updated cohort 2010-2018 cT1 + LVI compared to T2 w/o LVI asā¦.
0
5
0
RT @tompowles1: Bladder cancer session #JSMO25 - Longer term follow up for EVP showing 34 months median OS and 2 year median duration of reā¦.
0
8
0
Not only a great surgeon & the @SUO_YUO @MoffittGUOnc fellowship director, but an innovative researcher. Congrats on your TIL therapy trial Dr @michael_poch.
Urologist Michael Poch, MD (@Michael_Poch) shares insights on an innovative trial exploring TIL therapy for bladder cancer. This study is pushing boundaries and applying #TILtherapy to a new type of cancer. Read more: #CancerResearch
0
1
18
RT @MoffittNews: Urologist Michael Poch, MD (@Michael_Poch) shares insights on an innovative trial exploring TIL therapy for bladder cancerā¦.
0
8
0
RT @CanesDavid: Twitter/X vs reality. Hope your Mondaying is going well, and that this puts a smile on your face. #pcsm.#roboticprostatectoā¦.
0
19
0
RT @ACOSurgeons: Don't miss this year's Theodore F. Classen Memorial Lecture at the ACA in September! Not yet registered? Take advantage ofā¦.
0
1
0
RT @JulioPowSangMD: GU medical oncology faculty members @JadChahoud and Jingsong Zhang showcasing research opportunities to our incoming @Mā¦.
0
3
0
0
1
0
RT @drenriquegrande: ā”ļø Clinical Validation of the Intermediate-risk Nonāmuscle-invasive Bladder Cancer Scoring System and Substratificatioā¦.
0
4
0
Itās a privilege to work alongside the @USFUrology residents who rotate at @MoffittNews. Thank you for the honor of being named TOTY, especially when there are so many deserving faculty.
9
5
45
RT @MoffittGUOnc: Congrats to our 2025 match class! Looking forward to working with you!!@kendrick_yim @davidjnusbaum @renzogdg @MoffittNewā¦.
0
8
0
RT @JulioPowSangMD: Thank you @uroegg for visiting with us @MoffittNews! Great talks on GG1 prostate histology, surgeon's burnout and naā¦.
0
2
0
RT @tompowles1: New data from EV302 Enfortumab Vedotin & pembrolizumab for upper tract disease (~25% of pts). UTUC has distinct biologicalā¦.
0
79
0
RT @uretericbud: How fast do patients _actually_ recover from TURBT?. Prospectively collected data via text-message based ecological momentā¦.
0
27
0
RT @brian_rini: New table highlighting results in IMDC favorable risk RCC across IO-based doublets and nivo/pembro monotx trials. Major cavā¦.
0
78
0